Adalimumab retreatment successfully restores clinical response and health-related quality of life in patients with moderate to severe psoriasis who undergo therapy interruption.
about
Adalimumab retreatment successfully restores clinical response and health-related quality of life in patients with moderate to severe psoriasis who undergo therapy interruption.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Adalimumab retreatment success ...... undergo therapy interruption.
@en
Adalimumab retreatment success ...... undergo therapy interruption.
@nl
type
label
Adalimumab retreatment success ...... undergo therapy interruption.
@en
Adalimumab retreatment success ...... undergo therapy interruption.
@nl
prefLabel
Adalimumab retreatment success ...... undergo therapy interruption.
@en
Adalimumab retreatment success ...... undergo therapy interruption.
@nl
P2093
P2860
P356
P1476
Adalimumab retreatment success ...... undergo therapy interruption.
@en
P2093
A B Gottlieb
K B Gordon
K T Belasco
M Sundaram
P van de Kerkhof
R G Langely
P2860
P304
P356
10.1111/JDV.12677
P577
2014-10-03T00:00:00Z